Related Experiment Video
Updated: Sep 21, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
The Binding Mode of the Sonic Hedgehog Inhibitor Robotnikinin, a Combined Docking and QM/MM MD Study
Manuel Hitzenberger1,2, Daniela Schuster3, Thomas S Hofer1
1Theoretical Chemistry Division, Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.
Abstract:
Erroneous activation of the Hedgehog pathway has been linked to a great amount of cancerous diseases and therefore a large number of studies aiming at its inhibition have been carried out. One leverage point for novel therapeutic strategies targeting the proteins involved, is the prevention of complex formation between the extracellular signaling protein Sonic Hedgehog and the transmembrane protein Patched 1. In 2009 robotnikinin, a small molecule capable of binding to and inhibiting the activity of Sonic Hedgehog has been identified, however in the absence of X-ray structures of the Sonic Hedgehog-robotnikinin complex, the binding mode of this inhibitor remains unknown. In order to aid with the identification of novel Sonic Hedgehog inhibitors, the presented investigation elucidates the binding mode of robotnikinin by performing an extensive docking study, including subsequent molecular mechanical as well as quantum mechanical/molecular mechanical molecular dynamics simulations. The attained configurations enabled the identification of a number of key protein-ligand interactions, aiding complex formation and providing stabilizing contributions to the binding of the ligand. The predicted structure of the Sonic Hedgehog-robotnikinin complex is provided via a PDB file as Supplementary Material and can be used for further reference.
Insights
This study reveals how robotnikinin binds to Sonic Hedgehog, a key protein in cancer development. Understanding these interactions aids in designing new drugs to inhibit the Hedgehog pathway and fight cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Chemistry
Background:
- Aberrant Hedgehog pathway activation is implicated in numerous cancers.
- Inhibiting the Sonic Hedgehog (SHH)-Patched 1 (PTCH1) interaction is a therapeutic target.
- Robotnikinin is a known inhibitor of Sonic Hedgehog, but its binding mode is uncharacterized.
Purpose of the Study:
- To elucidate the binding mode of robotnikinin to Sonic Hedgehog.
- To identify key interactions stabilizing the Sonic Hedgehog-robotnikinin complex.
- To provide a structural basis for developing novel Sonic Hedgehog inhibitors.
Main Methods:
- Extensive molecular docking studies.
- Molecular dynamics (MD) simulations.
- Quantum mechanics/molecular mechanics (QM/MM) simulations.
Main Results:
- Detailed characterization of the Sonic Hedgehog-robotnikinin binding mode.
- Identification of critical protein-ligand interactions.
- Stabilizing contributions to ligand binding elucidated.
Conclusions:
- The study provides a structural understanding of robotnikinin's inhibition of Sonic Hedgehog.
- The findings facilitate the design of new therapeutic agents targeting the Hedgehog pathway.
- A PDB file of the complex is available for further research.

